SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging in conversation as a satirical, community-driven project that leverages long-standing internet lore, with many proponents highlighting its cultural endurance and potential to challenge established market narratives. Investors are actively debating its status as a parody of traditional finance, while the community emphasizes the project's accessibility and its origins as a long-term satirical movement.

Maulcoin

Maulcoin is capturing market attention as the community rallies around its organic, meme-driven growth and a rejection of traditional, high-pressure marketing tactics. Investors are actively discussing the project's grassroots origins and the upcoming milestones intended to drive momentum and long-term engagement.

Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. It offers properties for rent to life science, agriculture technology (agtech), and technology tenants. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities (ARE) is currently drawing significant attention from investors who view the stock as deeply undervalued due to its historically low price-to-FFO ratios and substantial discounts to net asset value despite owning premium life science assets. While the broader market sentiment remains cautious regarding high interest rates and biotech sector headwinds, the community is actively debating whether current levels represent a generational buying opportunity or a deeper long-term correction.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is seeing intense community debate following disappointing quarterly earnings and the debut shareholder letter from new CEO Greg Abel, with investors sharply divided between those alarmed by the company's underperformance and those viewing the recent pullback as a strategic buying opportunity for a firm sitting on a record cash pile.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense social media momentum and high trading volume driven by its vision to integrate decentralized finance into the global live music and event ecosystem. The community is actively debating the token's growth potential and utility, with many traders closely monitoring for potential partnership announcements while others express caution regarding price volatility and potential sell-offs.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Crypto is trending as community members rally behind the revival of classic internet rage comics, emphasizing the project's ownership of original cultural domains and its commitment to building on the Solana network. Supporters are focused on long-term conviction, actively creating and sharing memes to fuel memetic power and establish the token as a leading, authentic OG meme.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

Troll is gaining significant momentum as investors draw parallels to the cultural longevity of iconic meme-based tickers like Doge and Pepe. The community is actively discussing the asset's potential for sustainable growth, emphasizing its recognizable branding as a key driver for long-term relevance in the memecoin space.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token is seeing strong market interest driven by its positioning in the decentralized, privacy-focused AI sector and significant utility upgrades, including recent token burns and reduced supply emissions. The community is actively discussing its momentum and low circulating supply, with many pointing to its integration of advanced models like DeepSeek as a catalyst for potential growth.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp is experiencing intense volatility and heavy retail attention as a low-float SPAC, with traders actively debating its potential for a massive short squeeze. The community is focused on the stock's thin liquidity and speculative nature, with many participants comparing its price action to previous high-momentum movers while remaining divided between bullish expectations of parabolic gains and concerns over potential pump-and-dump dynamics.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors highlight its "phygital" brand strategy, specifically citing its massive retail presence in major chains and the launch of the Pengu Visa Card as key drivers for long-term utility. The community is actively discussing accumulation opportunities and comparing the project's unique revenue-generating model against traditional meme coins during this market phase.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Poxel To Sell PXL770 To Scynexis For Up To $196 Mln; Shares Up

(RTTNews) - Poxel SA (POXEL.PA, PXXLF), a clinical-stage biopharmaceutical company, on Tuesday announced that it has agreed to sell its drug candidate PXL770 to Scynexis, Inc. (SCYX), for up to $196 million...

<ul class="summary-bullets"><li>Scynexis signed a definitive agreement to acquire SCY-770, a novel oral therapy to treat Autosomal Dominant Polycystic Kidney Disease.</li><li>The biotech firm will pay $8 million upfront to Poxel and up to another $8 million tied to development milestones.</li><li>The company plans to begin a Phase 2 study of SCY-770 in late 2026.</li></ul>Shares of Scynexis, Inc. (SCYX) gave up most of their early gains but traded around 2% higher in pre-market on Tuesday after the biotech firm announced a deal with Poxel S.A. to acquire a potential treatment for a kidney disease, alongside securing $40 million through a private placement.Scynexis signed a definitive agreement to acquire PXL-770, now renamed SCY-770, a novel oral therapy to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD), a leading cause of kidney failure.Under the agreement, Scynexis will pay $8 million upfront and up to another $8 million tied to development milestones. The company could also pay up to $180 million in commercial milestones, including $125 million if annual sales reach $1 billion or more.<h2 class="st-heading-2">Scynexis To Begin Phase 2 Study Of SCY-770 In Late 2026</h2>The company plans to begin a Phase 2 study in late 2026, with early results expected in the second half of 2027. The therapy has also received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA).The oral therapy is designed to target the root causes of ADPKD by slowing cyst growth and limiting disease progression.“SCY-770 is supported by a strong pre-clinical data package and a novel differentiated MOA that targets multiple key drivers of ADPKD progression, positioning it as a promising candidate in a significant rare disease market with a high unmet need. Our near-term priority is to efficiently advance SCY-770 into a Phase 2 POC study later this year,” said David Angulo, President and CEO of Scynexis.Separately, Scynexis said it expects to raise about $40 million upfront from the private placement, with the potential to bring in up to an additional $52.2 million if all warrants are exercised for cash.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/SCYX">SCYX</a> on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, amid ‘extremely high’ message volumes.One user said they want to see the company being bought out.<stembedurl>https://stocktwits.com/ViktorSinclair/message/649025612</stembedurl>Another user said the company should remain focused on the anti-fungal space.<stembedurl>https://stocktwits.com/Varus_q/message/649029010</stembedurl>Pre-market volumes were strong, with 7.8 million shares changing hands, compared with an average of around 0.4 million, according to Stocktwits data.Year-to-date, the stock has gained around 25%.For updates and corrections, email newsroom[at]stocktwits[dot]com

Tariff uncertainty has prompted several analysts to cut their price targets for Five9 stock. 

  Scynexis In Spotlight After Poxel Deal, $40 Million Private Placement – SCYX Stock Climbs 2% Pre-Market

The biotech firm announced a deal to acquire a potential treatment for a kidney disease and secured $40 million through a private placement.

Equity

SCYNEXIS Q4 Earnings Assessment

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.

Current Price	$1.00
Prev Close	$0.992
Open	$1.01
Dividend Yield	0.00%
50-Day Moving Average	$0.8274
Beta	1.03
Avg. Volume	840,412.17
PE Ratio	-7.24

52-Week High	$1.31
52-Week Low	$0.565
Market Capitalization	$44.66M
EPS (Annual)	-$0.1724
Price to Book	0.88
Revenue Per Employee	$1.14M

SCYX
Scynexis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SCYX News

SCYXScynexis Inc